Literature DB >> 15885787

Differential expression of vascular endothelial growth factor implies the limbal origin of pterygia.

Matthias Gebhardt1, Rolf Mentlein, Ulrich Schaudig, Thomas Pufe, Kristin Recker, Bernhard Nölle, Kais Al-Samir, Gerd Geerling, Friedrich P Paulsen.   

Abstract

OBJECTIVE: To study the distribution of isoforms of vascular endothelial growth factor (VEGF) and its receptors VEGFR1 and VEGFR2 in pterygia and to compare it with that in healthy conjunctivas.
DESIGN: Nonrandomized comparative (cadaver controlled) study with histopathologic correlations.
METHODS: Tissue specimens from 75 patients treated for primary pterygia were analyzed using immunohistochemical studies as well as different molecular biological examinations. Healthy conjunctivas from 33 patients treated for cataracts as well as specimens from the conjunctiva, limbus, and lens of both eyes of 12 body donors served as controls. TESTING: Surgical specimens of pterygia and normal conjunctiva specimens were processed with paraffin, sectioned, stained using specific antibodies against VEGF and its receptors, and examined by light microscopy. The other part of both groups of specimens as well as specimens from body donors were prepared and analyzed by means of reverse-transcription polymerase chain reaction (RT-PCR), real-time RT-PCR, enzyme-linked immunosorbent assay, and Western blots. MAIN OUTCOME PARAMETERS: Vascular endothelial growth factor and VEGFR1 and VEGFR2 were analyzed to indentify the splice variants of VEGF as well as the distribution and amount of VEGF and both receptors in pterygia and the control tissues.
RESULTS: In analysis of specimens from pterygium patients as well as normal conjunctivas, VEGF121 and VEGF165 were identified as the only VEGF splice forms expressed. In addition to VEGF, VEGFR1 and VEGFR2 were detected in pterygia and conjunctivas and immunostained within the epithelium of pterygia and conjunctivas and on intrapterygial and intraconjunctival endothelial cells. Levels of VEGFR1 and VEGFR2 mRNA were lower in pterygia than in conjunctivas but similar in limbal and pterygium samples. Vascular endothelial growth factor levels were higher in pterygia than in conjunctivas, but were similar in the limbus and pterygia.
CONCLUSIONS: The results reveal similar behaviors in limbal and pterygium epithelial cells in terms of VEGF and VEGFR expression, with the presumption that pterygia arise from limbal epithelial cells and that human conjunctivas are not a suitable control for the analysis of pterygia. Moreover, the results suggest that VEGF might play an active role in the physiology of conjunctival epithelial cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15885787     DOI: 10.1016/j.ophtha.2005.01.023

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  18 in total

1.  [Pterygium. Etiology, clinical aspects and novel adjuvant therapies].

Authors:  L M Heindl; C Cursiefen
Journal:  Ophthalmologe       Date:  2010-06       Impact factor: 1.059

2.  Subconjunctival bevacizumab in the impending recurrent pterygia.

Authors:  Sezin Akca Bayar; Cem Kucukerdonmez; Ozlem Oner; Yonca A Akova
Journal:  Int Ophthalmol       Date:  2013-09-12       Impact factor: 2.031

3.  Does topical bevacizumab prevent postoperative recurrence after pterygium surgery with conjunctival autografting?

Authors:  Aylin Karalezli; Cem Kucukerdonmez; Yonca A Akova; Bengu Ekinci Koktekir
Journal:  Int J Ophthalmol       Date:  2014-06-18       Impact factor: 1.779

4.  Non-invasive detection of HPV DNA in exfoliative samples from ophthalmic pterygium: a feasibility study.

Authors:  Αikaterini K Chalkia; Stavros Derdas; Georgios Bontzos; George Sourvinos; Εfstathios T Detorakis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-11-09       Impact factor: 3.117

5.  Role of oxidative stress and vascular endothelial growth factor expression in pterygium pathogenesis and prevention of pterygium recurrence after surgical excision.

Authors:  Sameh Mohamed Elgouhary; Hesham Fouad Elmazar; Mariana Ibrahim Naguib; Noha Rabie Bayomy
Journal:  Int Ophthalmol       Date:  2020-06-06       Impact factor: 2.031

6.  Efficacy and Safety of a Large Conjunctival Autograft for Recurrent Pterygium.

Authors:  Jun Seok Lee; Sang Won Ha; Sung Yu; Gwang Ja Lee; Young Jeung Park
Journal:  Korean J Ophthalmol       Date:  2017-12

7.  Correlation of vascular endothelial growth factor and CD105-microvascular density in primary pterygium.

Authors:  Jie Zhang; Mingchang Zhang; Xiaoqing Li; Tian Zheng; Ge Mu; Wei Liu; Huatao Xie; Xin Liu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-08-07

8.  Liquid nitrogen cryotherapy for surface eye disease (an AOS thesis).

Authors:  Frederick Web Fraunfelder
Journal:  Trans Am Ophthalmol Soc       Date:  2008

9.  Expression of vascular endothelial growth factor C in human pterygium.

Authors:  Junichi Fukuhara; Satoru Kase; Tsutomu Ohashi; Ryo Ando; Zhenyu Dong; Kousuke Noda; Takeshi Ohguchi; Atsuhiro Kanda; Susumu Ishida
Journal:  Histochem Cell Biol       Date:  2012-08-23       Impact factor: 4.304

10.  Effect of single subconjunctival injection of bevacizumab on primary pterygium: clinical, histopathological and immunohistochemical study.

Authors:  Tarek A Mohamed; Wael Soliman; Ahmed M Fathalla; Abeer El Refaie
Journal:  Int J Ophthalmol       Date:  2018-05-18       Impact factor: 1.779

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.